Heartflow (NASDAQ:HTFL) CEO Sells $643,017.00 in Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 22,562 shares of the company’s stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $28.50, for a total transaction of $643,017.00. Following the sale, the chief executive officer directly owned 496,835 shares in the company, valued at $14,159,797.50. This trade represents a 4.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Monday, May 11th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $29.12, for a total transaction of $657,005.44.
• On Friday, April 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $26.72, for a total transaction of $602,856.64.
• On Wednesday, March 18th, John C.M. Farquhar sold 9,725 shares of Heartflow stock. The shares were sold at an average price of $25.00, for a total transaction of $243,125.00.

Heartflow Stock Performance

Shares of NASDAQ:HTFL opened at $33.24 on Monday. Heartflow, Inc. has a 52-week low of $20.13 and a 52-week high of $41.22. The company has a market capitalization of $2.87 billion and a P/E ratio of -10.69. The company has a 50-day simple moving average of $29.30 and a 200 day simple moving average of $28.32.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings results on Thursday, May 14th. The company reported ($0.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.08. The business had revenue of $52.59 million for the quarter. The business’s quarterly revenue was up 41.3% on a year-over-year basis. As a group, equities analysts forecast that Heartflow, Inc. will post -0.82 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have issued reports on HTFL. Piper Sandler reaffirmed an “overweight” rating on shares of Heartflow in a report on Thursday. JPMorgan Chase & Co. decreased their price objective on shares of Heartflow from $40.00 to $35.00 and set an “overweight” rating on the stock in a report on Thursday, March 19th. Wells Fargo & Company raised their target price on shares of Heartflow from $35.00 to $37.00 and gave the stock an “overweight” rating in a research note on Friday, May 15th. Canaccord Genuity Group reduced their target price on shares of Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a report on Friday, May 15th. Finally, William Blair initiated coverage on shares of Heartflow in a research note on Monday, May 4th. They issued an “outperform” rating on the stock. Six equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $37.00.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. TrueMark Investments LLC increased its position in Heartflow by 1.4% during the 1st quarter. TrueMark Investments LLC now owns 26,885 shares of the company’s stock worth $654,000 after buying an additional 379 shares during the period. Caitong International Asset Management Co. Ltd acquired a new position in shares of Heartflow in the fourth quarter valued at about $27,000. Strs Ohio grew its stake in shares of Heartflow by 35.3% in the first quarter. Strs Ohio now owns 4,600 shares of the company’s stock valued at $112,000 after acquiring an additional 1,200 shares in the last quarter. Russell Investments Group Ltd. bought a new position in Heartflow during the fourth quarter worth about $45,000. Finally, Legal & General Group Plc acquired a new stake in Heartflow in the 3rd quarter worth about $59,000.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.